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Abstract
Background: HPV infection causes cervical cancer, mediated in part by the degradation of Scribble via the HPV E6
oncoprotein. Recently, Scribble has been shown to be an important regulator of the Hippo signaling cascade.
Deregulation of the Hippo pathway induces an abnormal cellular transformation, epithelial to mesenchymal
transition, which promotes oncogenic progression. Given the recent rise in oropharyngeal HPV squamous cell
carcinoma we sought to determine if Hippo signaling components are implicated in oropharyngeal squamous cell
carcinoma.
Methods: Molecular and cellular techniques including immunoprecipiations, Western blotting and immunocytochemistry
were used to identify the key Hippo pathway effector Yes-Associated Protein (YAP)1. Oropharyngeal tissue
was collected from CO2 laser resections, and probed with YAP1 antibody in tumor and pre-malignant regions
of HPV positive OPSCC tissue.
Results: This study reveals that the Scribble binding protein Nitric Oxide Synthase 1 Adaptor Protein
(NOS1AP) forms a complex with YAP. Further, the NOS1APa and NOS1APc isoforms show differential
association with activated and non-activated YAP, and impact cellular proliferation. Consistent with
deregulated Hippo signaling in OPSCC HPV tumors, we see a delocalization of Scribble and increased nuclear
accumulation of YAP1 in an HPV-positive OPSCC.
Conclusion: Our preliminary data indicates that NOS1AP isoforms differentially associate with YAP1, which,
together with our previous findings, predicts that loss of YAP1 enhances cellular transformation. Moreover,
YAP1 is highly accumulated in the nucleus of HPV-positive OPSCC, implying that Hippo signaling and possibly
NOS1AP expression are de-regulated in OPSCC. Further studies will help determine if NOS1AP isoforms,
Scribble and Hippo components will be useful biomarkers in OPSCC tumor biology.
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Background
Oropharyngeal squamous cell carcinoma (OPSCC) has
traditionally been a disease associated with long-term
use of tobacco and alcohol. In recent decades there has
been a shift in the demographics of the OPSCC patient:
the majority are now younger, otherwise healthy, non-
drinkers and non-smokers. It is widely accepted that this
shift is secondary to infection with Human Papilloma
Virus (HPV). HPV-16 is commonly associated with a
high risk of carcinogenesis, and is found in up to 90% of
HPV positive OPSCCs [1–3]. The molecular mechanism
of HPV-induced carcinogenesis has been well studied in
cervical cancer and there is a growing body of literature
concerning its effects in the oropharynx.
HPV is a small virus that infects squamous epithelium.
It gives rise to two clusters of proteins: early (E1-7) and
late (L1-2). The early genes E5, E6, and E7 all give rise
to oncoproteins with the remaining genes coding for
regulatory and structural proteins [4]. The oncoprotein
E6 causes ubiquitin mediated degradation of the tumor
suppressor P53, leading to a reduced rate of apoptosis
[4]. The oncoproteins from low-risk HPV strains (e.g.
HPV-6) are unable to target tumor suppressor proteins
as efficiently as high risk strains such as HPV-16 [4].
In addition to E6 degrading p53, recent studies have
shown a direct interaction between the HPV E6 protein
and the tumor suppressor protein Scribble, leading to the
degradation of Scribble [5, 6]. This interaction initiates
epithelial to mesenchymal transition (EMT) transition, an
early event in cellular transformation and oncogenesis [7].
Epithelial polarity is a fundamental process in cellular
growth and contact inhibition. Disruption of cellular po-
larity is a major contributor to carcinogenesis. Scribble
is a tumour suppressor protein that localizes to the
basolateral margins of polarized epithelial cells and plays
a major role in establishing cellular polarity [8]. Scribble
has also been linked to the intracellular transduction
pathway known as Hippo [9, 10]. Activation of the well
established Hippo cascade leads to the phosphorylation
and inactivation of Yes Associated Protein (YAP)1,
(hereafter referred to as YAP) and its retention in the
cytoplasm, whereas YAP dephosphorylation and activa-
tion locates it in the nucleus where it drives cellular pro-
liferation [10]. Deregulation of the Hippo pathway
occurs in a broad range of human carcinomas, including
lung, colorectal, breast, ovarian, pancreatic, gastric and
liver cancers [11–19]. YAP deregulation has been impli-
cated in other head and neck malignancies [20, 21], and
its expression has been associated with poor patient sur-
vival in esophageal cancers [20]. Increased YAP levels
and nuclear sequestration were associated with high-
grade oral squamous cell carcinoma (OSCC) [21], but it
is currently unknown if Hippo pathway deregulation
plays a role in OPSCC.
The improved survival and increased susceptibility of
HPV positive OPSCC to treatment has led to optimism.
Improved understanding of the mechanisms of HPV
modulated oncogenesis by different molecular carcino-
genic pathways can help in better understanding of
tumorgenesis and may lead to more effective targeted
therapy in the future. Given the recent rise in oropha-
ryngeal HPV related squamous cell carcinoma and the
link between Scribble-NOS1AP and HPV, we sought to
determine if Hippo signaling is implicated in such can-
cers. This study is the first to investigate Hippo signaling
and Scribble-NOS1AP disruption in OPSCC.
Methods
Samples Selection
P16, HPV positive OPSCC patient tissue was selected
randomly from the samples in the Anatomical Pathology
Department at the QEII Health Science Center. Any pa-
tient less than 18 year old, with HPV status uncertainty
or non- oropharyngeal squamous cell carcinoma were
excluded from the study. Tissue specimens were acquired
from CO2 laser wide local resection of OPSCC. Malig-
nant regions, as well as adjacent epithelia, were defined
by an onsite histopathologic examination. A portion of
the tissues were sectioned and used for hematoxylin and
eosin (H&E) staining and immunofluorescence imaging.
Sections (5 micron) of tissue were placed on OptiPlus
Positive-Charged Barrier Slides.
Reagents
All chemicals were purchased from Sigma, unless other-
wise noted.
Antibodies
YAP is a mouse monoclonal antibody raised against re-
combinant human YAP (Santa Cruz, sc-101199); Scribble
(H-300) (Santa Cruz – sc-28737) is a rabbit polyclonal
antibody raised amino acids 1331-1630 mapping at the
C-terminus of human Scribble; pLATS (Ser 909) Cell
Signaling (#9157). Pan-NOS1AP and the pep-NOS1APc
and GST-NOS1APc antibodies have previously been
described [22, 23].
Cell culture and transfections
Human embryonic kidney HEK293T or MCF7 cells
were grown at 37 °C with 5% carbon dioxide in Dulbec-
co's modified Eagle's medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 2
mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml
streptomycin.
Immunoprecipitations and Western blotting
Cell lines were homogenized in NP-40 lysis buffer (10%
glycerol, 1% NP-40, 20 mM Tris [pH 8.0], 37.5 mM
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NaCl) containing 1 mM phenylmethylsulfonyl fluoride
(PMSF), 10 μg/ml aprotinin, and 10 μg/ml leupeptin.
Immunoprecipitation (IP) and Western blotting experi-
ments were performed as previously reported [22]. For
analysis of YAP and phospho-YAP levels in HEK293T
cells, protein concentration in whole-cell lysates was
quantified using the Bradford assay [24], and lysates were
prepared for immunoprecipitation (IP) and Western
blotting.
Immunohistochemistry (IHC)
Tissues were embedded in paraffin then cut in thin sec-
tions and preserved for further staining. The sections
were then deparaffinized in xylene followed by rehydra-
tion through graded ethanol/water until rehydrated in
phosphate buffered saline (PBS). Sections were then
blocked in 5% normal goat serum containing 0.1% Tri-
ton X-100 in PBS. They were then incubated in blocking
solution containing anti-YAP and anti-Scribble antibody
overnight at 4°C. They were then washed 3 times in PBS
followed by incubation with fluorescently labeled sec-
ondary antibodies for 1 h at room temperature. Sections
were extensively washed in PBS, incubated in Hoechst
33342 (Life Science Technologies), suspended in PBS
prior to mounting onto slides and imaging. All images
were captured on a Leica DM6100 inverted microscope
with appropriate filter sets using Intelligent Imaging In-
novations (3i) software for acquisition. All post hoc im-
aging was done with Photoshop 6.0.
Thymidine incorporation studies
A thymidine incorporation assay was used to analyze
serum-induced proliferation of YFP, YFP-NOS1APa or
YFP-NOS1APc stable cell lines as described previously
[23]. The incorporation of 1 μCi/ml radioactive [methyl-
3H] thymidine (Perkin-Elmer) into cellular DNA during
a 15-min pulse time was quantified by liquid scintillation
counting. The entire assay was repeated in two independ-
ent experiments, and the data are the averages from four
independent replicates in each experiment.
Results
NOS1AP and Scribble associate with the Hippo signaling
component YAP
The tumor suppressor protein Scribble associates with
YAP and regulates Hippo signaling [25, 26]. In a recent
report [23], we showed that the nitric oxide synthase 1
adaptor protein (NOS1AP), and an extended splice vari-
ant, NOS1APc, associate with Scribble. Further, we have
showed that NOS1AP can associate with YAP [23]; how-
ever, whether both NOS1APa and NOS1APc associate
with YAP and regulates Hippo signaling remains un-
known. This is relevant as both NOS1APa and
NOS1APc have different subcellular localizations within
the cell and associate with different protein complexes
[23]. Here we tested whether NOS1APa and NOS1APc
could precipitate YAP equally. To test this, we immuno-
precipitated equal amounts of lysate from either 293T
cells (Fig. 1a) or rat brain lysate (Fig. 1b) with either a
pre-immune antibody, a NOS1APc isoform specific anti-
body (pep-NOS1APc) or a pan-NOS1AP antibody,
which detects multiple NOS1AP isoforms, including
NOS1APa [23]. The resulting precipitates were then
probed for YAP. The pan-NOS1AP and NOS1APc spe-
cific antibodies precipitated YAP, as previously shown
[23]. However, the NOS1APc antibody precipitated less
YAP in both the 293T cells and in the rat brain lysates,
relative to the pan-NOS1AP antibody (arrow, left panel,
Fig. 1a), suggesting that NOS1APc does not associate
with YAP to the same extent as some of the other
NOS1AP isoforms.
Distinct NOS1AP isoforms associate with phosphorylated
YAP
Activation of Hippo signaling induces a kinase-
signaling cascade leading to the phosphorylation of
conserved serine residues in YAP. Since we found that
YAP associated differentially with different NOS1AP
isoforms, we next wanted to determine if NOS1AP iso-
forms could preferentially associate with phosphory-
lated or non-phosphorylated YAP. To test this, we
precipitated the different NOS1AP isoforms with the
pan-NOS1AP or NOS1APc isoform specific antibodies
(pep-NOS1APc) and probed for phosphorylated
YAP (pYAP). Interestingly, the pep- NOS1APc anti-
body was able to precipitate pYAP while the pan-
NOS1AP antibody showed little or no recognition for
pYAP (arrows, upper panel, Fig. 2). Since Scribble has
been shown to interact with YAP [27], we wanted to
test whether Scribble could also interact with pYAP.
Indeed, Scribble was able to associate with pYAP
(upper panel, Fig. 2). Together this suggests that the
different NOS1AP isoforms preferentially associate
with either non-phosphorylated or phosphorylated
YAP, whereas Scribble can associate with both.
NOS1AP regulates cellular proliferation
Given that Hippo signaling is linked to cellular prolifera-
tion and that the differential associations of the NOS1AP
isoforms with non-phosphorylated or phosphorylated
YAP, we next considered whether overexpression of
NOS1AP isoforms would affect cellular proliferation. Here
MCF7 cells were used as deregulation of either Scribble or
Hippo signaling affects proliferation in these cells. MCF7
cells stably expressing YFP, YFP-NOS1APa or YFP-
NOS1APc were monitored for proliferation rates in 10%
serum following serum starvation. Interestingly,
NOS1APa and NOS1APc showed significantly lower
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levels of thymidine incorporation compared to YFP at
48 h (**p < 0.01) and at 72 h (***p < 0.001) in 10% serum
(Fig. 3). However, no significant difference between YFP-
NOS1APa and YFP-NOS1APc was observed at indicated
time points (Fig. 3). Together, this supports the notion
that both NOS1AP isoforms affect cellular proliferation
and may function as a tumor suppressor.
YAP accumulates in the nucleus of HPV-OPSCCs
In cervical cancers, HPV infections have been shown to
lead to the degradation of Scribble leading to EMT tran-
sition [18]. Since Scribble associates with NOS1AP and
both Scribble and NOS1AP regulate Hippo signaling, we
next tested whether HPV positive OPSCC showed
deregulated Hippo signaling. Here sections from an
HPV positive OPSCC were stained with YAP (Fig. 4a–f ).
In malignant cells, the transcriptional co-activator YAP
was found in the nucleus (Fig. 4e and f, arrows).
Notably, in adjacent pre-cancerous tissue, although most
of the YAP was cytosolic, some YAP was observed to ac-
cumulate in the nucleus. In non-cancerous tissue, YAP
was restricted from the nucleus (Fig. 4c and d).
Discussion
The Hippo Pathway is a tumor suppressor pathway that
was first described in Drosophila. It is involved in coord-
inating numerous proteins involved in diverse biological
processes that have been implicated in terminal differen-
tiation, and deregulation of this pathway leads to cancer
[8]. It has been shown in vitro that human Scribble is
targeted for degradation by the high-risk HPV E6 pro-
teins [5]. More than 90% of endocervical cancers are
HPV related [28]. Nakagawa et al. was the first to de-
scribe a link between Scribble and HPV [17]. Subsequent
studies have linked higher-grade human endometrial
lesions to higher degradation of Scribble protein [29].
a
b
Fig. 1 NOS1AP isoforms associate with YAP. a HEK293T cell lysate was Immunoprecipitated with the antibodies indicated. The resulting blot was
probed with anti-YAP (arrow, left panel) and re-probed with a NOS1APc specific antibody (pep-NOS1APc) (arrow, right panel). Note, more YAP
associates with the pan-NOS1AP antibody than with the NOS1APc antibody. b Rat brain cell lysate was immunoprecipitated with the indicated antibodies.
The resulting blot was probed with anti-YAP antibody (arrow, left panel) and then re-probed with a NOS1APc specific antibody (pep-NOS1APc) (arrow,
right panel). Asterisk denote cross reacting bands
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Recently, Hippo signaling has been linked to various
cancers, and scribble has been shown to be an important
mediator of Hippo signaling [25, 26]. In the current
study, we sought to test if the human homologue of
Scribble is involved in HPV positive OPSCC. We were
able to demonstrate that Scribble [23] and its associating
protein NOS1AP both precipitate YAP. Further, we
found that different NOS1AP isoforms associate with
non-phosphorylated YAP and phosphorylated YAP. The
exogenous expression of both NOS1APa and NOS1APc
affect cellular proliferation suggesting that both NOS1AP
isoforms are involved in cellular growth. Finally, our pre-
liminary results suggest a link between the Hippo pathway
and the Scribble-NOS1AP axis in HPV related OPSCC.
Notably, we found enrichment of YAP in the nucleus of
malignant cells in HPV OPSCC, which was absent in be-
nign adjacent cells (Fig. 4) implicating that YAP might
provide a useful biomarker in HPV-OPSCC.
In cultured epithelial cells, the formation of cell-cell
contacts is an important step in the terminal differenti-
ation before the development of distinct apico-basal sur-
faces [10, 30]. Recently, the transcriptional co-activator
YAP was implicated in this process [10]. A number of
groups have now shown that cell-cell contacts induce
the activation of the LATS1/2 serine/threonine kinases
that phosphorylate YAP [31–33]. Upon phosphorylation,
YAP becomes restricted from the nucleus preventing the
transcription of genes important in cell cycle progression
[9.10]. A recent cervical cancer study showed that in
high-grade cervical lesions nuclear levels of YAP are
Fig. 3 NOS1AP isoforms affects cellular proliferation. Starved MCF7
cells stably expressing YFP-NOS1APa and YFP-NOS1APc incorporate
less radiolabeled thymidine over a 48 and 72h period with 10% serum
relative to MCF7 cells stably expressing YFP. Differences were considered
significant in Students t-test at **P< 0.01, ***p < 0.001
Fig. 2 NOS1APc associates with pYAP. Rat brain cell lysate was
immunoprecipitated with the antibodies indicated the resulting
blot was probed with the antibodies indicated (upper panel pYAP (ser
127). Lower panel, blot was re-probed with a pan-NOS1AP antibody to




Fig. 4 YAP is activated in HPV+ve-OPSCC. a, b HPV+ve -OPSCC stained
with anti-YAP (a) and Hoechst (b). Note: Solid line is tumor margin
(a, b). Boxed regions in (a) are expanded in (c) left box and (e) right
box. (c, d) Enlarged region ( left box in a) showing Yap (c) and nuclei
(d). Note, Yap is mainly localized to small puncta in the cytosol in
tumor margins, with some cells showing YAP accumulation in the
nucleus (c, d arrow). e, f Enlarged region (right box in a) showing Yap
(e) and nuclei (f). Note, Yap is localized in the nucleus in tumor
(e, f, arrows). Scale bar = 50um
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increased [34]. Additionally, nuclear YAP levels are also
increased in premalignant oral lesions [35]. YAP has
been found to be an independent prognostic marker for
overall survival in liver cancer [36], and Xiao et al.,
showed that YAP can function as a predictive marker for
cervical cancer [34]. These considerations suggest that
discerning to what extent Scribble, NOS1AP and the
Hippo pathway intersect with HPV-mediated OPSCC
will be an important goal for future work.
The HPV E6 protein is known to directly associate
with Scribble and induce its degradation through prote-
asome mediated degradation; however, how this is linked
to Hippo signaling activity remains unclear. Recent work
has demonstrated that both the tumor suppressor func-
tions of Scribble and the Hippo pathway are genetically
linked to tissue growth regulation, and EMT transition
[9, 37, 38]. We suggest one important avenue of research
is to focus on the adaptor protein NOS1AP. Here we
have shown that the NOS1AP isoforms associate with
Hippo signaling components as well as with Scribble.
Further, we show a differential association of NOS1AP
isoforms with cytoplasmic localized and nuclear accu-
mulated YAP. Similarly, we also show that Scribble asso-
ciates with both differentially localized forms of YAP
(Figs. 1 and 2). Whether these interactions with YAP are
related to the distinct subcellular localizations of the dif-
ferent NOS1AP isoforms remains to be determined.
Interestingly, in neurons endogenous NOS1APa has
been reported in the nucleus where non-phosphorylated
YAP is found [39]. However, stable expression of
NOS1APa is membrane localized in epithelial cell lines,
and co-distributes with cytoplasmic YAP [23]. Thus,
whether YAP can associate with NOS1APa at cell-cell
contacts in a non-phosphorylated or phosphorylated
state remains to be explored. Despite the association of
the different NOS1AP isoforms with distinct localized
YAP pools, both NOS1APa and NOS1APc are capable
of reducing cellular proliferation, consistent with previ-
ous work showing that NOS1APa functions as a tumor
suppressor in breast cancer models [40]. How NOS1AP
functions to control Hippo signaling will be an import-
ant future focus in cancer biology.
The recent significant rise of HPV related OPSCC has
led to a search for alternative pathways that might be
more amenable to targeted therapies in future. It is also
foreseeable that some of the involved proteins could be
subjects for tumor diagnostics and prognosis. To date,
we have observed this finding in one patient with HPV
positive OPSCC with YAP localizing to the nucleus in
tumor tissue. This work follows from another recent
study showing that YAP levels are increased in HNSCC
[41]. Our current work extends this by demonstrating
that in a HPV-OPSCC patient, YAP is localized in the
nucleus, suggesting that Hippo signaling is possibly an
important signaling pathway with relevance to HPV
positive OPSCC, and to HNSCC in general. Further un-
derstanding of the signaling pathways utilized by the dif-
ferent NOS1AP isoforms may provide insight into the
underlying biology of OPSCC, and may be an important
biomarker in this context. As such, more patients with
HPV-positive OPSCC are being recruited to extend our
findings and to develop a sense of how the Scribble-
NOS1AP-Hippo signaling cascade may differ according
to cancer grade.
Conclusion
In this study the tumor suppressor protein Scribble asso-
ciates with both YAP and phosphorylated YAP. Interest-
ingly, the Scribble associating protein NOS1AP shows
differential association with transcriptionally active and
inactive YAP, indicating that distinct isoforms cooperate
with the Hippo pathway to inhibit YAP. Further we
show that YAP localizes to the nucleus in HPV positive
OPSCC while in the pre-malignant tissues YAP is not
enriched in the nucleus. Together our study implicates
the potential importance of the Hippo pathway in
OPSCC and points to the NOS1AP isoforms as potential
biomarkers in this process.
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